Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net income	$ 4,204,424	$ 3,438,534
Adjustments to reconcile net income to net cash provided by operating activities -
Amortization of deferred financing costs	98,695	129,131
Depreciation	3,711	4,595
Non cash compensation expense	13,065	13,065
Loss on write-down of investment in privately held company		20,000
Changes in operating assets and liabilities
Interest receivable on loans	(61,732)	(188,526)
Other current and non current assets	(19,753)	323
Accounts payable and accrued expenses	16,157	62,019
Deferred origination fees	106,205	(16,940)
Net cash provided by operating activities	4,360,772	3,462,201
Cash flows from investing activities:
Issuance of short term loans	(51,859,000)	(37,871,500)
Collections received from loans	42,146,873	27,502,820
Purchase of fixed assets	(1,148)	(1,666)
Net cash used in investing activities	(9,713,275)	(10,370,346)
Cash flows from financing activities:
Proceeds from public offering, net	9,882,780
(Repayments of) proceeds from line of credit, net	(292,447)	10,431,746
Dividends paid	(3,998,825)	(3,288,621)
Proceeds from exercise of stock options and warrants	48,735	20,440
Purchase of treasury shares	(48,743)	(172,156)
Deferred financing costs incurred	(20,381)	(43,122)
Net cash provided by financing activities	5,571,119	6,948,287
Net increase in cash and restricted cash	218,616	40,142
Cash and restricted cash, beginning of year	136,441	96,299
Cash and restricted cash, end of year	355,057	136,441
Supplemental Cash Flow Information:
Taxes paid during the year	642	2,971
Interest paid during the year	1,584,508	1,034,097
Supplement Information - Noncash Information:
Dividend declared and payable	$ 1,158,717	$ 891,983